Biotech is shifting to hub-and-spoke models to share infrastructure, reduce single-asset risk, and build repeatable engines ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #1 is a biotech by the name of Aldeyra Therapeutics (ALDX). The reason why i want to go over this biotech ...
BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, biotechnology companies are placing greater ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
Hosted on MSN
Mantis biotech unveils virtual patient models
Mantis Biotech has emerged from stealth with significant funding to develop AI-driven 'digital twins'—virtual patient models built from diverse biological data. The technology aims to address ...
INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Biotechnology startups are creating tiny models of human organs in an effort to speed the search for novel drugs. By devising more realistic models of human and disease biology, these startups aim to ...
Discover how shared core facilities help biotech startups reduce capital expenditures, access advanced equipment, accelerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results